序号 |
标题 |
次数 |
作者 |
发布时间 |
75421 |
Au_55_C10COOH 金团簇55-C10-羧酸 |
79 |
h |
2024-12-19 |
75422 |
Au-S-(CH2)10-C(O)-CH3 金-硫-直链烷烃10-碳(氧)-甲烷3 |
116 |
h |
2024-12-19 |
75423 |
MC-Val-Cit-PAB-tubulysin5a ,CAS号:2055896-86-9 |
71 |
WYQ |
2024-12-19 |
75424 |
Au_55_C11NH3Cl 金55-C11-NH3Cl |
102 |
h |
2024-12-19 |
75425 |
(S-(CH2)11-(beta-Lactose(SO4Na)7)2 硫-十一烷烃-β-乳糖 |
121 |
h |
2024-12-19 |
75426 |
HS-(CH2)11-O-Disperse Red 1 十一烷烃硫醇化荧光配体 |
177 |
h |
2024-12-19 |
75427 |
HS-(CH2)16-(EG)2 -N(+)(CH3)2-CH2-COO(-) 二聚乙二醇化十六硫醇 |
123 |
h |
2024-12-19 |
75428 |
cas:103750-03-4,5-Maleimido-pentanoic NHS ester,5-马来酰亚胺戊酸NHS |
123 |
kx |
2024-12-19 |
75429 |
4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate,抗体药物偶联物(ADC) |
121 |
kx |
2024-12-19 |
75430 |
cas:158913-22-5,SPDP-C6-NHS ester,琥珀酰亚胺基6-[3-(2-吡啶基二硫代)丙酰胺基]己酸酯 |
118 |
kx |
2024-12-19 |
75431 |
perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate,抗体药物偶联物(ADC) |
127 |
kx |
2024-12-19 |
75432 |
cas:663598-61-6,2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate, ADC试剂 |
98 |
kx |
2024-12-19 |
75433 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 |
82 |
kx |
2024-12-19 |
75434 |
cas:160580-70-1,perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,抗体药物偶联物(ADC) |
141 |
kx |
2024-12-19 |
75435 |
cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 |
142 |
kx |
2024-12-19 |
75436 |
MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 |
90 |
WYQ |
2024-12-19 |
75437 |
cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 |
104 |
kx |
2024-12-19 |
75438 |
mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) |
92 |
WYQ |
2024-12-19 |
75439 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
98 |
wyh |
2024-12-19 |
75440 |
MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) |
98 |
WYQ |
2024-12-19 |
75441 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
76 |
wyh |
2024-12-19 |
75442 |
MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) |
93 |
WYQ |
2024-12-19 |
75443 |
N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB |
122 |
kx |
2024-12-19 |
75444 |
MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) |
84 |
WYQ |
2024-12-19 |
75445 |
MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 |
108 |
WYQ |
2024-12-19 |
75446 |
叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB |
88 |
kx |
2024-12-19 |
75447 |
MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 |
109 |
WYQ |
2024-12-19 |
75448 |
MC-Sq-Cit-PAB-Gefitinib(CAS:1941168-63-3) |
171 |
WYQ |
2024-12-19 |
75449 |
HS-(CH2)m-(EG)n -N(+)(CH3)2-CH2-COO(-) 聚乙二醇化直链烷烃硫醇 |
98 |
h |
2024-12-19 |
75450 |
Mal-PEG4-Val-Ala-PAB,马来酰亚胺-四聚乙二醇-VAL-ALA-PAB |
132 |
kx |
2024-12-19 |
75451 |
MC-GGFG-DX8951(CAS:1600418-29-8) |
289 |
WYQ |
2024-12-19 |
75452 |
(HO)2-PO-S-(CH2)6-EG2-OH 硫-(2-羟基六烷-1-基)硫代磷酸酯 |
130 |
h |
2024-12-19 |
75453 |
Au_55_C11EG4Carboxybetaine 金团簇55-羧基甜菜碱 |
127 |
h |
2024-12-19 |
75454 |
(HO)2-PO-S-(CH2)m-COONHS 硫-(2,5-二氧代 - 吡咯烷-1-基氧基羰基)-1-基硫代磷酸 |
100 |
h |
2024-12-19 |
75455 |
2529982-76-9,Azido-PEG4-Val-Ala-PAB,叠氮-四聚乙二醇-VAL-ALA-PAB |
116 |
kx |
2024-12-19 |
75456 |
Au_12_C11EG6 金团簇12-直链烷烃六聚乙二醇 |
142 |
h |
2024-12-19 |
75457 |
cas:863971-17-9 ,MC-Val-Cit-PAB-MMAF,MC-VAL-CIT-PAB-MMAF游离态 |
85 |
kx |
2024-12-19 |
75458 |
CF3-(CF2)5-C2-O-C11-Si(OMe)3 巯基-直链烷烃连接氟化硫醇和硅烷 |
110 |
h |
2024-12-19 |
75459 |
cas:2353409-69-3 , Mal-PEG8-Val-Cit-PAB-MMAE,马来酰亚胺-八聚乙二醇-VAL-CIT-PAB-MMAE |
93 |
kx |
2024-12-19 |
75460 |
cas:2129164-91-4 , DBCO-PEG4-Val-Cit-PAB-MMAE,二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-MMAE |
155 |
kx |
2024-12-19 |
75461 |
MAL-di-EG-Val-Cit-PAB-MMAF,由ADC连接桥(MAL-di-EG-Val-Cit-PAB)和有效的微管蛋白聚合阻断剂(MMAF, Monomethyl auristatin F)组成 |
118 |
WYQ |
2024-12-19 |
75462 |
MAL-di-EG-Val-Cit-PAB-MMAE,CAS编号:2746391-62-6 |
130 |
WYQ |
2024-12-19 |
75463 |
cas:644981-35-1 , Val-Cit-PAB-MMAE, ADC试剂 |
78 |
kx |
2024-12-19 |
75464 |
cas:2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE,抗体药物偶联物(ADC) |
153 |
kx |
2024-12-19 |
75465 |
AcLys-PABC-VC-Aur0101(CAS:1438851-17-2) |
110 |
WYQ |
2024-12-19 |